Citigroup
HLTH

Citigroup’s Cue Health Inc. Common Stock HLTH Stock Holding History

Citigroup’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,906
Closed -$843 – 5900
2023
Q3 		$843 Sell
1,906
-807
-30% -$368 ﹤0.01% 5121
2023
Q2 		$1K Buy
2,713
+1,012
+59% +$864 ﹤0.01% 5335
2023
Q1 		$3.1K Sell
1,701
-870
-34% -$1.89K ﹤0.01% 5031
2022
Q4 		$5.32K Buy
2,571
+922
+56% +$2.91K ﹤0.01% 5019
2022
Q3 		$5K Sell
1,649
-16,962
-91% -$60.1K ﹤0.01% 5254
2022
Q2 		$60K Buy
18,611
+17,272
+1,290% +$93.6K ﹤0.01% 4463
2022
Q1 		$9K Sell
1,339
-2,584
-66% -$23.4K ﹤0.01% 5604
2021
Q4 		$53K Buy
+3,923
New +$43.2K ﹤0.01% 5039

Other funds holding HLTH

TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return
OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
JPC
Jabodon PT Co Reno, Nevada $1.02B AUM 22.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's HLTH Position: Q4 2023 in Review

Citigroup sold out of Cue Health Inc. Common Stock (HLTH) in Q4 2023, closing a stake of 1,906 shares — an estimated $843 sold.

Citigroup first reported a position in HLTH in Q4 2021 and held it in 8 quarters. The position peaked at $60K in Q2 2022. 63 funds tracked by Wall St. Rank hold HLTH as of Q4 2023.

  • Citigroup reported no remaining Cue Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Citigroup sold 1,906 Cue Health Inc. Common Stock shares in Q4 2023, an estimated $843.
  • Citigroup first reported a position in Cue Health Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Citigroup's Cue Health Inc. Common Stock position peaked at $60K in Q2 2022.
  • 63 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q4 2023.

Based on Citigroup's 13F filing for Q4 2023, filed 9 Feb 2024.